ID 400310622 · FY 2021–2024 · 4 years
Pharmaceutical importer/distributor active in the Georgian market.
curated 2026-06-03reportal.ge
| Line item | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|
| Total Revenue | 775 | 34,191 | 48,230 | 65,941 | +339.8% |
| Total COGS | -674 | -18,932 | -19,376 | -24,855 | +232.9% |
| Gross Profit | 101 | 15,259 | 28,854 | 41,086 | nmf |
| Gross Margin | 13.1% | 44.6% | 59.8% | 62.3% | |
| Total Operating Expenses | -119 | -3,245 | -5,993 | -7,024 | +289.3% |
| EBITDA | -18 | 12,014 | 22,861 | 34,062 | nmf |
| EBITDA Margin | -2.3% | 35.1% | 47.4% | 51.7% | |
| Total D&A | -31 | -27 | -83 | -290 | +109.7% |
| EBIT / Operating Income | -49 | 11,987 | 22,778 | 33,772 | nmf |
| Total Other Income | -14 | 130 | -254 | -229 | +155.6% |
| Profit Before Tax | -63 | 12,117 | 22,524 | 33,543 | nmf |
| Total Income Tax | -13 | -59 | -239 | -293 | +180.7% |
| Net Profit / (Loss) | -76 | 12,058 | 22,285 | 33,250 | nmf |
| Net Margin | -9.8% | 35.3% | 46.2% | 50.4% |
Ownership & directors from companyinfo.ge (public corporate registry).